Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Nanotechnology ; 23(40): 405706, 2012 Oct 12.
Article in English | MEDLINE | ID: mdl-22995919

ABSTRACT

Si nanowires (NWs) integrated in a field effect transistor device structure are characterized using scanning electron (SEM), atomic force, and scanning Kelvin probe force (KPFM) microscopy. Reactive ion etching (RIE) and vapor-liquid-solid (VLS) growth were used to fabricate NWs between predefined electrodes. Characterization of Si NWs identified defects and/or impurities that affect the surface electronic structure. RIE NWs have defects that both SEM and KPFM analysis associate with a surface contaminant as well as defects that have a voltage dependent response indicating impurity states in the energy bandgap. In the case of VLS NWs, even after aqua regia, Au impurity levels are found to induce impurity states in the bandgap. KPFM data, when normalized to the oxide-capacitance response, also identify a subset of VLS NWs with poor electrical contact due to nanogaps and short circuits when NWs cross that is not observed in AFM images or in current-voltage measurements when NWs are connected in parallel across electrodes. The experiments and analysis presented outline a systematic method for characterizing a broad array of nanoscale systems under device operation conditions.

2.
Oncogene ; 30(26): 2954-63, 2011 Jun 30.
Article in English | MEDLINE | ID: mdl-21339740

ABSTRACT

Mammalian target of rapamycin complex (mTORC) regulates a variety of cellular responses including proliferation, growth, differentiation and cell migration. In this study, we show that mammalian target of rapamycin complex 2 (mTORC2) regulates invasive cancer cell migration through selective activation of Akt1. Insulin-like growth factor-1 (IGF-1)-induced SKOV-3 cell migration was completely abolished by phosphatidylinositol 3-kinase (PI3K) (LY294002, 10 µM) or Akt inhibitors (SH-5, 50 µM), whereas inhibition of extracellular-regulated kinase by an ERK inhibitor (PD98059, 10 µM) or inhibition of mammalian target of rapamycin complex 1 (mTORC1) by an mTORC1 inhibitor (Rapamycin, 100 nM) did not affect IGF-1-induced SKOV-3 cell migration. Inactivation of mTORC2 by silencing Rapamycin-insensitive companion of mTOR (Rictor), abolished IGF-1-induced SKOV-3 cell migration as well as activation of Akt. However, inactivation of mTORC1 by silencing of Raptor had no effect. Silencing of Akt1 but not Akt2 attenuated IGF-1-induced SKOV-3 cell migration. Rictor was preferentially associated with Akt1 rather than Akt2, and over-expression of Rictor facilitated IGF-1-induced Akt1 activation. Expression of PIP3-dependent Rac exchanger1 (P-Rex1), a Rac guanosine exchange factor and a component of the mTOR complex, strongly stimulated activation of Akt1. Furthermore, knockdown of P-Rex1 attenuated Akt activation as well as IGF-1-induced SKOV-3 cell migration. Silencing of Akt1 or P-Rex1 abolished IGF-1-induced SKOV-3 cell invasion. Finally, silencing of Akt1 blocked in vivo metastasis, whereas silencing of Akt2 did not. Given these results, we suggest that selective activation of Akt1 through mTORC2 and P-Rex1 regulates cancer cell migration, invasion and metastasis.


Subject(s)
Cell Movement , Neoplasms/pathology , Proto-Oncogene Proteins c-akt/agonists , TOR Serine-Threonine Kinases/metabolism , Cell Movement/drug effects , Cell Movement/genetics , Cells, Cultured , Enzyme Activation/drug effects , Enzyme Activation/genetics , Enzyme Activation/physiology , Gene Expression Regulation, Neoplastic/drug effects , Guanine Nucleotide Exchange Factors/metabolism , Guanine Nucleotide Exchange Factors/physiology , Humans , Insulin-Like Growth Factor I/pharmacology , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasms/genetics , Neoplasms/metabolism , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , RNA, Small Interfering/pharmacology , Substrate Specificity , rac1 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/physiology
3.
Oncogene ; 28(9): 1241-7, 2009 Mar 05.
Article in English | MEDLINE | ID: mdl-19151757

ABSTRACT

The serine/threonine protein kinase, Akt/PKB, has an essential function in cell survival during response to various stresses. Recent studies have demonstrated that Akt isoforms exhibit some distinct physiological functions, but the isotype-specific functions for Akt in the stress response have not been fully identified. In this study, we analysed the cellular response to genotoxic stress using isogenic wild-type, Akt1(-/-) and Akt2(-/-) mouse embryonic fibroblasts (MEFs). Marked hypersensitivity of Akt2(-/-) MEFs was observed to UV irradiation, whereas wild-type and Akt1(-/-) MEFs showed comparable levels of resistance. Akt2(-/-) mouse aortic endothelial cells also showed hypersensitivity to UV and the reconstitution of Akt2 expression in the Akt2(-/-) MEFs restored the UV resistance of the cells. Interestingly, upon UV irradiation, JNK and p38 were significantly upregulated in Akt2(-/-) MEFs, compared to wild-type and Akt1(-/-) MEFs. Additionally, inhibition of JNK and p38 activation reduced UV-induced cell death. Furthermore, both the hyperactivation of JNK and p38 and the UV-induced cell death in Akt2(-/-) MEFs were completely inhibited by restoring Akt2 expression. These results indicate that Akt2, but not Akt1, is essential for cell survival upon UV irradiation, and that Akt2 prevents UV-induced cell death by inhibiting activation of JNK and p38.


Subject(s)
Cell Survival , MAP Kinase Kinase 4/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Ultraviolet Rays , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Apoptosis , Blotting, Western , Cell Cycle , Enzyme Activation , Mice
4.
Mar Biotechnol (NY) ; 8(4): 425-32, 2006.
Article in English | MEDLINE | ID: mdl-16761197

ABSTRACT

Genomic analysis of a hyperthermophilic archaeon Thermococcus sp. NA1 revealed the presence of an 885-bp open reading frame encoding a protein of 295 amino acids with a calculated molecular mass of 32,981 Da. Analysis of the deduced amino acid sequence showed that amino acid residues important for catalytic activity and the metal binding ligands conserved in all of methionyl aminopeptidases (MetAP) were also conserved and belonged to type IIa MetAP. The protein, designated TNA1_MetAP (Thermococcus sp. NA1 MetAP), was cloned and expressed in Escherichia coli. The recombinant enzyme was a Mn(2+)-, Ni(2+)-, Fe(2+)-, or Co(2+)-dependent metallopeptidase. Optimal MetAP activity against L: -methionine p-nitroanilide (Met-pNA) (K (m) = 0.68 mM) occurred at pH 7.0 and 80 to 90 degrees C. The MetAP was very unstable compared to Pyrococcus furiosus MetAP, which was completely inactivated by heating at 80 degrees C for 5 min. It seemed likely that the cysteine residue (Cys53) played a critical role in regulating the thermostability of TNA1_MetAP.


Subject(s)
Aminopeptidases/biosynthesis , Aminopeptidases/genetics , Thermococcus/enzymology , Thermococcus/genetics , Amino Acid Sequence , Aminopeptidases/chemistry , Aminopeptidases/drug effects , Cloning, Molecular/methods , DNA Primers/chemistry , Escherichia coli/genetics , Hot Temperature , Metals/pharmacology , Methionyl Aminopeptidases , Molecular Sequence Data , Oceans and Seas , Recombinant Proteins/biosynthesis , Recombinant Proteins/drug effects , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Thermococcus/physiology , Time Factors
5.
Vet Rec ; 150(2): 35-7, 2002 Jan 12.
Article in English | MEDLINE | ID: mdl-11829064

ABSTRACT

A PCR was used to determine the genotypic prevalence of five fimbrial adhesins (F4, F5, F6, F41 and F18), two heat-stable enterotoxins (STa and STb), the heat-labile enterotoxin (LT), and the shiga toxin 2e (Stx2e) in 230 isolates of Escherichia coli from postweaning pigs with diarrhoea or oedema disease. Ninety-four (40.9 per cent) of the isolates carried genes for at least one of the fimbrial adhesins or toxins. Genes for the F18 fimbrial adhesin were detected in 18.3 per cent, and genes for F4, F6, F5 and F41 were detected in 10.0 per cent, 4.3 per cent, 1.7 per cent and 0.8 per cent of the isolates, respectively. Genes for STa, STb and LT were detected in 25.7 per cent, 15.2 per cent and 8.7 per cent of the isolates, respectively. Genes for Stx2e were detected in 36 (15.6 per cent) of the isolates, and among them 24 also contained the gene for F18ab and four also contained the gene for F18ac.


Subject(s)
Adhesins, Escherichia coli/genetics , Bacterial Toxins/genetics , Diarrhea/veterinary , Edema Disease of Swine/genetics , Adhesins, Escherichia coli/isolation & purification , Animals , Bacterial Toxins/isolation & purification , Diarrhea/epidemiology , Diarrhea/genetics , Edema Disease of Swine/epidemiology , Genotype , Korea/epidemiology , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Prevalence , Swine
6.
J Leukoc Biol ; 69(3): 490-6, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11261798

ABSTRACT

The tumor necrosis factor receptor (TNFR)-associated factor (TRAF) proteins play a central role in the early steps of signal transduction by TNFR superfamily proteins, which induce various cellular responses, including apoptosis. Influences of TRAF proteins on the regulation of cell death and physical interactions between TRAFs and caspases have been reported. In this study, we demonstrate that TRAF3 is proteolyzed during cell death in a caspase-dependent manner. TRAF3 was found to be cleaved by incubation with caspase3 in vitro and by Fas- or CD3-triggering in Jurkat-T cells. The Fas- or CD3-induced cleavage of TRAF3 was blocked by caspase inhibitors and by introduction of alanine substitutions for D347 and D367 residues. Furthermore, the amino-terminal fragment of TRAF3 showed a different intracellular localization from the full-length TRAF3 with preferential distribution to particulate fractions and the nucleus. These findings suggest that TRAF3 may be regulated by caspases during apoptosis of T cells.


Subject(s)
Caspases/metabolism , Jurkat Cells/metabolism , Membrane Glycoproteins/pharmacology , Proteins/metabolism , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Apoptosis/drug effects , Apoptosis/physiology , COS Cells/enzymology , COS Cells/metabolism , Caspase 3 , Caspase Inhibitors , Cysteine Proteinase Inhibitors , Fas Ligand Protein , HeLa Cells , Humans , Jurkat Cells/drug effects , Jurkat Cells/enzymology , Muromonab-CD3/pharmacology , Oligopeptides/pharmacology , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , TNF Receptor-Associated Factor 3
7.
FEBS Lett ; 491(1-2): 4-8, 2001 Feb 23.
Article in English | MEDLINE | ID: mdl-11226408

ABSTRACT

Upon epidermal growth factor treatment, phospholipase C-gamma1 (PLC-gamma1) translocates from cytosol to membrane where it is phosphorylated at tyrosine residues. Caveolae are small plasma membrane invaginations whose structural protein is caveolin. In this study, we show that the translocation of PLC-gamma1 and its tyrosine phosphorylation are localized in caveolae by caveolin-enriched low-density membrane (CM) preparation and immunostaining of cells. Pretreatment of cells with methyl-beta-cyclodextrin (MbetaCD), a chemical disrupting caveolae structure, inhibits the translocation of PLC-gamma1 to CM as well as phosphatidylinositol (PtdIns) turnover. However, MbetaCD shows no effect on tyrosine phosphorylation level of PLC-gamma1. Our findings suggest that, for proper signaling, PLC-gamma1 phosphorylation has to occur at PtdInsP(2)-enriched sites.


Subject(s)
Caveolae/metabolism , Epidermal Growth Factor/metabolism , Isoenzymes/metabolism , Phosphatidylinositols/metabolism , Signal Transduction , Type C Phospholipases/metabolism , Tyrosine/metabolism , beta-Cyclodextrins , Animals , Blotting, Western , COS Cells , Caveolae/enzymology , Caveolae/ultrastructure , Caveolin 1 , Caveolins/metabolism , Cell Compartmentation , Cell Line , Cell Membrane/enzymology , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Cyclodextrins/pharmacology , Hydrolysis , Phospholipase C gamma , Phosphorylation , Precipitin Tests
8.
FEBS Lett ; 491(1-2): 16-20, 2001 Feb 23.
Article in English | MEDLINE | ID: mdl-11226410

ABSTRACT

Apoptotic proteases cleave and inactivate survival signaling molecules such as Akt/PKB, phospholipase C (PLC)-gamma1, and Bcl-2. We have found that treatment of A431 cells with tumor necrosis factor-alpha in the presence of cycloheximide resulted in the cleavage of epidermal growth factor receptor (EGFR) as well as the activation of caspase-3. Among various caspases, caspase-1, caspase-3 and caspase-7 were most potent in the cleavage of EGFR in vitro. Proteolytic cleavage of EGFR was inhibited by both YVAD-cmk and DEVD-fmk in vitro. We also investigated the effect of caspase-dependent cleavage of EGFR upon the mediation of signals to downstream signaling molecules such as PLC-gamma1. Cleavage of EGFR by caspase-3 significantly impaired the tyrosine phosphorylation of PLC-gamma1 in vitro. Given these results, we suggest that apoptotic protease specifically cleaves and inactivates EGFR, which plays crucial roles in anti-apoptotic signaling, to abrogate the activation of EGFR-dependent downstream survival signaling molecules.


Subject(s)
Caspases/metabolism , ErbB Receptors/metabolism , Isoenzymes/metabolism , Type C Phospholipases/metabolism , Amino Acid Chloromethyl Ketones/pharmacology , Amino Acid Sequence , Caspase 1/metabolism , Caspase 2 , Caspase 3 , Caspase 7 , Caspase Inhibitors , Cysteine Proteinase Inhibitors/pharmacology , Humans , Molecular Sequence Data , Oligopeptides/pharmacology , Peptide Hydrolases/metabolism , Phospholipase C gamma , Phosphorylation , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Tyrosine/metabolism
9.
Toxicol Appl Pharmacol ; 169(1): 1-7, 2000 Nov 15.
Article in English | MEDLINE | ID: mdl-11076690

ABSTRACT

Polychlorinatedbiphenyls (PCBs) are a group of persistent and widely dispersed environmental pollutants, some of which may be immunotoxic. In the present study, we investigated the effect of PCBs on immune system by assessing apoptotic cell death in human monocytic U937 cells. Among the various congeners tested, 2,2',4,6, 6'-pentachlorobiphenyl (PeCB), a highly ortho-substituted congener, specifically induced DNA fragmentation, a hallmark of apoptosis, while the other examined di-, tri-, tetra-, and pentachlorobiphenyls did not. To further study the 2,2',4,6,6'-PeCB-induced cell death, various features of apoptosis were examined. 2,2',4,6,6'-PeCB caused a decrease in cell viability and induced cellular morphologic features characteristic of apoptosis such as chromatin aggregation and apoptotic bodies. In addition, caspase-3, an executioner of apoptosis, was activated and its substrate, poly(ADP-ribose) polymerase (PARP), was cleaved during 2,2',4,6,6'-PeCB-induced apoptosis. In contrast, 3,3',4,4',5-PeCB, a congener of coplanar structure, as well as 2,3,7,8-TCDD did not induce apoptosis in these human monocytic cells, although they potently induced CYP 1A1 in human hepatoma Hep G2 cells. Taken together, the data indicate that 2,2',4,6,6'-PeCB induces apoptosis in human monocytic cells through a mechanism that is independent of the arylhydrocarbon receptor. This suggests a possibly separate mechanism by which PCBs cause immunosuppression.


Subject(s)
Apoptosis/drug effects , Environmental Pollutants/toxicity , Monocytes/drug effects , Polychlorinated Biphenyls/toxicity , Carcinoma, Hepatocellular , Caspase 3 , Caspases/biosynthesis , Cell Nucleus/pathology , Cell Survival/drug effects , Cells, Cultured , Coloring Agents/metabolism , DNA/drug effects , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Humans , Liver Neoplasms , Monocytes/cytology , Monocytes/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Polychlorinated Dibenzodioxins/toxicity , Receptors, Aryl Hydrocarbon/metabolism , Tetrazolium Salts/metabolism , Thiazoles/metabolism , Trypan Blue/metabolism , U937 Cells/cytology , U937 Cells/drug effects
10.
Mol Cells ; 10(4): 469-74, 2000 Aug 31.
Article in English | MEDLINE | ID: mdl-10987147

ABSTRACT

Phospholipase C (PLC)-gamma1 plays a pivotal role in the signal transduction pathway mediated by growth factors. In this study, we found that neurite outgrowth of pheochromocytoma (PC12) cells was significantly induced by interleukin-6 (IL-6). Stimulation of PC12 cells with IL-6 led to tyrosine phosphorylation of PLC-gamma1 in a dose- and time-dependent manner. IL-6 stimulation also increased the hydrolysis of phosphatidylinositol 4,5-bisphosphate. Accumulation of total inositol phosphate as well as tyrosine phosphorylation of PLC-gamma1 was inhibited by the pretreatment of protein kinase inhibitors such as genistein and staurosporine. These results suggest that PLC-gamma1 may be involved in the signal transduction pathway of IL-6-induced PC12 cell differentiation.


Subject(s)
Interleukin-6/pharmacology , Isoenzymes/physiology , Neurons/metabolism , Phosphotyrosine/metabolism , Type C Phospholipases/physiology , Animals , Genistein/pharmacology , Inositol Phosphates/metabolism , Isoenzymes/metabolism , Neurites/drug effects , Neurites/metabolism , Neurons/cytology , Neurons/drug effects , PC12 Cells , Phospholipase C gamma , Phosphorylation , Phosphotyrosine/drug effects , Protein-Tyrosine Kinases/antagonists & inhibitors , Rats , Signal Transduction , Type C Phospholipases/metabolism
11.
FASEB J ; 14(9): 1083-92, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10834929

ABSTRACT

Apoptosis is a cell suicide mechanism that requires the activation of cellular death proteases for its induction. We examined whether the progress of apoptosis involves cleavage of phospholipase C-gamma1 (PLC-gamma1), which plays a pivotal role in mitogenic signaling pathway. Pretreatment of T leukemic Molt-4 cells with PLC inhibitors such as U-73122 or ET-18-OCH(3) potentiated etoposide-induced apoptosis in these cells. PLC-gamma1 was fragmented when Molt-4 cells were treated with several apoptotic stimuli such as etoposide, ceramides, and tumor necrosis factor alpha. Cleavage of PLC-gamma1 was blocked by overexpression of Bcl-2 and by specific inhibitors of caspases such as Z-DEVD-CH(2)F and YVAD-cmk. Purified caspase-3 and caspase-7, group II caspases, cleaved PLC-gamma1 in vitro and generated a cleavage product of the same size as that observed in vivo, suggesting that PLC-gamma1 is cleaved by group II caspases in vivo. From point mutagenesis studies, Ala-Glu-Pro-Asp(770) was identified to be a cleavage site within PLC-gamma1. Epidermal growth factor receptor (EGFR) -induced tyrosine phosphorylation of PLC-gamma1 resulted in resistance to cleavage by caspase-3 in vitro. Furthermore, cleaved PLC-gamma1 could not be tyrosine-phosphorylated by EGFR in vitro. In addition, tyrosine-phosphorylated PLC-gamma1 was not significantly cleaved during etoposide-induced apoptosis in Molt-4 cells. This suggests that the growth factor-induced tyrosine phosphorylation may suppress apoptosis-induced fragmentation of PLC-gamma1. We provide evidence for the biochemical relationship between PLC-gamma1-mediated signal pathway and apoptotic signal pathway, indicating that the defect of PLC-gamma1-mediated signaling pathway can facilitate an apoptotic progression.


Subject(s)
Apoptosis , Isoenzymes/metabolism , Type C Phospholipases/metabolism , Amino Acid Sequence , Amino Acid Substitution/genetics , Animals , Apoptosis/drug effects , Caspase 3 , Caspase 7 , Caspase Inhibitors , Caspases/metabolism , Ceramides/pharmacology , ErbB Receptors/metabolism , Etoposide/pharmacology , Isoenzymes/antagonists & inhibitors , Isoenzymes/genetics , Mice , Molecular Weight , Mutation/genetics , Phospholipase C gamma , Phosphorylation , Phosphotyrosine/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/pharmacology , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/genetics
12.
J Chromatogr A ; 814(1-2): 83-95, 1998 Jul 24.
Article in English | MEDLINE | ID: mdl-9718688

ABSTRACT

The relative efficacy of a variety of low-molecular-mass displacers was examined using a displacer ranking plot. This method enables an evaluation of the dynamic affinity of a variety of displacers over a range of operating conditions. Several homologous series of molecules were evaluated to provide insight into the effects of various structural features on displacer efficacy. The results indicate that linear flexible geometries may have advantages over branched or cyclic structures. Data also indicate that the spreading out of charges may increase affinity. The incorporation of aromatic moieties in these displacers, particularly near the surface of the molecules, appears to result in a dramatic increase in displacer affinity. The ability of several high-affinity low-molecular-mass displacers a very strongly bound cationic protein is also examined. The results confirm the predictions of the theory and indicate that it is indeed possible to displace highly bound macromolecules with low-molecular-mass dispatchers. The work presented in this paper indicates that non-specific interactions can be exploited for producing high-affinity low-molecular-mass displacers.


Subject(s)
Chromatography, Ion Exchange/standards , Algorithms , Chromatography, High Pressure Liquid , Indicators and Reagents , Ligands , Molecular Weight , Protein Binding , Spectrophotometry, Ultraviolet
13.
J Neurochem ; 71(1): 178-85, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9648864

ABSTRACT

Phospholipase C gamma1 (PLC-gamma1) is phosphorylated on treatment of cells with nerve growth factor (NGF). To assess the role of PLC-gamma1 in mediating the neuronal differentiation induced by NGF treatment, we established PC12 cells that overexpress whole PLC-gamma (PLC-gamma1PC12), the SH2-SH2-SH3 domain (PLC-gamma1SH223PC12), SH2-SH2-deleted mutants (PLC-gamma1deltaSH22PC12), and SH3-deleted mutants (PLC-gamma1deltaSH3PC12). Overexpressed whole PLC-gamma1 or the SH2-SH2-SH3 domain of PLC-gamma1 stimulated cell growth and inhibited NGF-induced neurite outgrowth of PC12 cells. However, cells expressing PLC-gamma1 lacking the SH2-SH2 domain or the SH3 domain had no effect on NGF-induced neuronal differentiation. Overexpression of intact PLC-gamma1 resulted in a threefold increase in total inositol phosphate accumulation on treatment with NGF. However, overexpression of the SH2-SH2-SH3 domain of PLC-gamma1 did not alter total inositol phosphate accumulation. To investigate whether the SH2-SH2-SH3 domain of PLC-gamma1 can mediate the NGF-induced signal, tyrosine phosphorylation of the SH2-SH2-SH3 domain of PLC-gamma1 on NGF treatment was examined. The SH2-SH2-SH3 domain of PLC-gamma1 as well as intact PLC-gamma1 could be tyrosine-phosphorylated on NGF treatment. These results indicate that the overexpressed SH2-SH2-SH3 domain of PLC-gamma1 can block the differentiation of PC12 cells induced by NGF and that the inhibition appears not to be related to the lipase activity of PLC-gamma1 but to the SH2-SH2-SH3 domain of PLC-gamma1.


Subject(s)
Isoenzymes/chemistry , Isoenzymes/metabolism , Nerve Growth Factors/pharmacology , Neurons/enzymology , Type C Phospholipases/chemistry , Type C Phospholipases/metabolism , src Homology Domains/genetics , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Division/drug effects , Cell Division/physiology , Gene Deletion , Gene Expression Regulation, Enzymologic , Inositol Phosphates/biosynthesis , Isoenzymes/genetics , Mutagenesis/physiology , Neurites/physiology , Neurons/cytology , Neurons/ultrastructure , PC12 Cells , Phospholipase C gamma , Phosphorylation , Rats , Signal Transduction/drug effects , Signal Transduction/physiology , Type C Phospholipases/genetics , Tyrosine/metabolism
14.
Biosci Biotechnol Biochem ; 62(1): 154-6, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9501529

ABSTRACT

2-Ketoaldonate reductase, which is involved in ketogluconate catabolism, was purified to homogeneity from Brevibacterium ketosoreductum ATCC21914. The enzyme was found to catalyze the reduction of 2,5-diketo-D-gluconate to 5-keto-D-gluconate, and to a lesser extent, 2-keto-D-gluconate to D-gluconate, and 2-keto-L-gluconate to L-idonate. The molecular mass of the reductase was 35 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and 72 kDa by gel filtration, indicating that the native enzyme may exist as a dimer. The reductase was optimally active at pH 6.0 with NADPH as a preferred electron donor. The pI of 4.7 was measured for the enzyme. The apparent Km for 2,5-diketo-D-gluconate and NADPH were 5 microM and 10 microM, respectively. The amino-terminal amino acid sequence was NH2-Ala-Ser-Ile-Ser-Val-Ser-Val-Pro-Ser-Ala- Arg-Leu-Ala-Glu-Asp-Leu-Ser-Asp-Ile-Glu.


Subject(s)
Brevibacterium/enzymology , Carbohydrate Dehydrogenases/isolation & purification , Escherichia coli Proteins , Amino Acid Sequence , Carbohydrate Dehydrogenases/metabolism , Hydrogen-Ion Concentration , Molecular Sequence Data , Substrate Specificity
15.
J Korean Med Sci ; 13(6): 685-8, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9886182

ABSTRACT

Colony-stimulating factors (CSFs) are commonly used for the treatment of neutropenia following chemotherapy and for the mobilization of peripheral blood stem cells (PBSC). We recently experienced a rare case of a new onset of psoriasiform eruption by GM-CSF (granulocyte-macrophage colony-stimulating factor) which was exacerbated by G-CSF (granulocyte colony-stimulating factor) in a patient with breast cancer. A 36-year-old woman had received neoadjuvant chemotherapy (cyclophosphamide, epirubicin and 5-fluorouracil), modified radical mastectomy and adjuvant chemotherapy with paclitaxel and mitoxantrone followed by GM-CSF administration for the treatment of locally advanced breast cancer. She had developed a psoriatic skin lesion on face and both upper arms during leukocyte recovery in spite of no previous history of psoriasis. Next, the chemotherapy course was complicated by a flare of mild psoriatic skin lesion, although CSF was changed into G-CSF due to GM-CSF-associated psoriasis. Subsequently, she had had high-dose chemotherapy and autologous peripheral blood stem cell transplantation for consolidation therapy. GM-CSF was administered for the mobilization of PBSC and post-transplant period, but psoriatic skin lesion did not appear. During 6 months after PBSCT, psoriasiform eruption did not appear.


Subject(s)
Breast Neoplasms/drug therapy , Granulocyte Colony-Stimulating Factor/adverse effects , Granulocyte-Macrophage Colony-Stimulating Factor/adverse effects , Psoriasis/chemically induced , Adult , Breast Neoplasms/complications , Carcinoma, Ductal, Breast/complications , Carcinoma, Ductal, Breast/drug therapy , Female , Humans , Neutropenia/chemically induced , Neutropenia/drug therapy , Recombinant Proteins
16.
J Chromatogr A ; 827(2): 295-310, 1998 Dec 11.
Article in English | MEDLINE | ID: mdl-9914657

ABSTRACT

The relative efficacy of a variety of low-molecular-mass displacers was examined on three different stationary phase materials. Several homologous series of displacer molecules were evaluated on these ion-exchange resins using a displacer ranking plot based on the steric mass action model. The results demonstrate that while aromaticity and hydrophobicity can play a significant role in the affinity of displacer molecules on polymethacrylate based and hydrophilized polystyrene-divinylbenzene based materials, this effect is much less pronounced on an agarose based resin. The work presented in this paper demonstrates that different structural features of low-molecular-mass displacers can dominate their affinity on various stationary phase materials employed and provides rules of thumb for the design of high affinity, low-molecular-mass displacers for a variety of commercial cation-exchange materials.


Subject(s)
Chromatography, Ion Exchange/methods , Cation Exchange Resins , Magnetic Resonance Spectroscopy , Molecular Structure , Spectrophotometry, Ultraviolet
17.
J Ind Microbiol Biotechnol ; 19(4): 294-8, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9439004

ABSTRACT

Bacillus thuringiensis subsp tochigiensis HD868 was identified as a bacteriocin producer which exhibited a bactericidal effect against closely related species. This bacteriocin designated as tochicin, was partially purified by 75% ammonium sulfate precipitation followed by subsequent dialysis. This partially purified tochicin showed a narrow antibacterial spectrum of activity against most of 20 typical B. thuringiensis strains and a strain of B. cereus, but not against other bacteria and yeasts tested. The antibacterial activity of tochicin on sensitive indicator cells disappeared completely by proteinase K treatment (1 mg ml-1), which indicates its proteinaceous nature. Tochicin was very stable throughout the range of pH 3.0-9.0 and was relatively heat-stable at 90 degrees C, but bacteriocin activity was not detected after boiling for 30 min. The relationship between cell growth and bacteriocin production was studied in a semi-defined medium. Tochicin activity was detected at the mid-log growth phase, reached the maximum at the early stationary phase, but decreased after the stationary phase. Direct detection of tochicin activity on sodium dodecyl sulfate-polyacrylamide gel suggested it has an apparent molecular mass of about 10.5 kDa. Tochicin exhibited a bactericidal activity against B. thuringiensis subsp thompsoni HD522 in phosphate buffer (pH 7.0).


Subject(s)
Bacillus thuringiensis/metabolism , Bacteriocins/isolation & purification , Electrophoresis, Polyacrylamide Gel , Hydrogen-Ion Concentration , Temperature
18.
J Biol Chem ; 271(41): 25213-9, 1996 Oct 11.
Article in English | MEDLINE | ID: mdl-8810281

ABSTRACT

A specific protein inhibitor of partially purified bovine brain phospholipase D (PLD) was identified from bovine brain cytosol. The PLD inhibitor has been enriched through several chromatographic steps and characterized with respect to size and mechanism of inhibition. The inhibitor showed an apparent molecular mass of 30 kDa by Superose 12 gel exclusion chromatography and inhibited PLD activity with an IC50 of 7 nM. The inhibitor had neither proteolytic activity nor phospholipid-hydrolyzing activity. Because phosphatidylinositol 4,5-bisphosphate (PIP2), which is included in substrate vesicles, is an essential cofactor for PLD, we examined whether the inhibition might be mediated by sequestration of PIP2. PIP2 hydrolysis by phospholipase C (PLC)-beta1 was not affected by the inhibitor and the inhibitor did not bind to substrate vesicles containing PIP2. In contrast, a PH domain derived from PLC-delta1, which could bind to PIP2, showed a nearly identical inhibition of both PLC-beta1 and PLD activities. Thus, the PLD inhibition by the inhibitor is due to the specific interaction with not PIP2 but PLD. The suppression of PLD activity by the inhibitor was largely eliminated by the addition of ADP-ribosylation factor (ARF) and GTPgammaS. We propose that the inhibitor plays a negative role in regulation of PLD activity by PIP2 and ARF.


Subject(s)
Brain/physiology , Enzyme Inhibitors/pharmacology , Nerve Tissue Proteins/pharmacology , Phospholipase D/isolation & purification , Animals , Brain/enzymology , Brain Chemistry , Cattle , Chromatography, Gel , Chromatography, Ion Exchange , Cytosol/physiology , Enzyme Inhibitors/isolation & purification , Isoenzymes/metabolism , Kinetics , Molecular Weight , Nerve Tissue Proteins/isolation & purification , Phosphatidylinositol 4,5-Diphosphate/metabolism , Phosphatidylinositol 4,5-Diphosphate/pharmacology , Phospholipase C beta , Type C Phospholipases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL